Wikipedia:Articles for creation/Categories

From Wikipedia, the free encyclopedia


Category Water-splashing festivals not found

Example pages which belong to this category:

Parent category/categories:

2A06:C701:4F15:9000:F56C:8F13:BEA6:542D (talk) 11:37, 30 April 2024 (UTC)[reply]


Example pages which belong to this category:

Parent category/categories:

The Sharpest Lives (contribs) 18:39, 12 May 2024 (UTC)[reply]

Please clarify why Category:Green Day albums is insufficient and these three albums would need their own special subcategory, especially given that a dedicated subcategory normally requires a minimum of five things. Bearcat (talk) 14:03, 25 May 2024 (UTC)[reply]


Example pages which belong to this category:

Parent category/categories:

92.71.60.61 (talk) 08:18, 13 May 2024 (UTC)[reply]


Example pages which belong to this category:

Parent category/categories:

92.71.60.61 (talk) 13:31, 15 May 2024 (UTC)[reply]


Example pages which belong to this category:

Parent category/categories:

92.71.60.61 (talk) 14:00, 16 May 2024 (UTC)[reply]


Example pages which belong to this category:

Parent category/categories:

92.71.60.61 (talk) 07:50, 17 May 2024 (UTC)[reply]


Example pages which belong to this category:

Parent category/categories:

92.71.60.61 (talk) 08:05, 17 May 2024 (UTC)[reply]

Category request: Category:Symmetrical flags[edit]


Example pages which belong to this category:

Parent category/categories:

92.71.60.61 (talk) 09:24, 17 May 2024 (UTC)[reply]

Category request: Category:Quadcolours flags[edit]


Example pages which belong to this category:

Parent category/categories:

92.71.60.61 (talk) 11:55, 17 May 2024 (UTC)[reply]


Example pages which belong to this category:

Parent category/categories:

92.71.60.61 (talk) 09:12, 28 May 2024 (UTC)[reply]

Category request: Category:health[edit]


Example pages which belong to this category:

Twillisjr (talk) 17:29, 31 May 2024 (UTC)[reply]

Lorazepam[edit]

Lorazepam, sold under the brand name Ativan among others, is a medication used to treat anxiety disorders. As a benzodiazepine, Lorazepam works by enhancing the effects of gamma-aminobutyric acid (GABA), a neurotransmitter that promotes relaxation and reduces neuronal excitability. This medication is commonly prescribed for anxiety, insomnia, seizures, and as a premedication for medical procedures. It is known for its potent, rapid onset of action and relatively short half-life.

History and Development

Lorazepam was first synthesized by Wyeth Pharmaceuticals in the 1960s. It was introduced to the market in the 1970s, primarily for the treatment of anxiety. Since its introduction, it has become one of the most commonly prescribed benzodiazepines worldwide due to its efficacy and safety profile when used appropriately.

[Structure and Pharmacology]

Lorazepam has the chemical formula C15H10Cl2N2O2 and a molecular weight of 321.16 g/mol. It is classified chemically as a 1,4-benzodiazepine, characterized by a benzene ring fused to a diazepine ring.

Upon administration, Lorazepam is well-absorbed, with peak plasma levels occurring approximately 2 hours after oral intake. It is metabolized in the liver, primarily via glucuronidation, and excreted through the urine. The elimination half-life of Lorazepam ranges from 10 to 20 hours, allowing for twice-daily dosing in most cases.

Medical Uses

Anxiety Disorders Lorazepam is widely used to manage various anxiety disorders, including generalized anxiety disorder (GAD), panic disorder, and social anxiety disorder. It is effective in reducing the acute symptoms of anxiety, such as restlessness, agitation, and excessive worry. Insomnia

Due to its sedative properties, Lorazepam is sometimes prescribed for short-term management of insomnia, particularly in patients who have difficulty falling asleep due to anxiety. Seizure Disorders

Lorazepam is an important medication in the management of status epilepticus, a life-threatening condition characterized by prolonged or repeated seizures. Its rapid onset of action makes it ideal for acute seizure control. Premedication for Medical Procedures

Lorazepam is often used as premedication before surgeries or other medical procedures to induce sedation, reduce anxiety, and produce amnesia for the event. Alcohol Withdrawal

Lorazepam is effective in managing symptoms of acute alcohol withdrawal, including tremors, agitation, and the risk of seizures. Dosage and Administration

Lorazepam is available in various forms, including tablets, oral solutions, and injectable formulations. The dosage and route of administration depend on the condition being treated, patient factors, and clinical judgment.

Anxiety: Typical oral doses range from 1 to 3 mg, two to three times daily. Insomnia: 1 to 2 mg at bedtime. Seizures: Intravenous or intramuscular injection of 4 mg, repeated if necessary. Premedication: 0.05 mg/kg IM, given 2 hours before surgery.

Mechanism of Action

Lorazepam binds to the benzodiazepine site on the GABA_A receptor complex in the central nervous system. This binding enhances the effects of GABA, the primary inhibitory neurotransmitter in the brain, leading to increased chloride ion influx and hyperpolarization of the neuronal membrane. The net effect is a reduction in neuronal excitability, producing anxiolytic, sedative, hypnotic, muscle relaxant, and anticonvulsant effects.

Side Effects

While Lorazepam is generally well-tolerated, it can cause side effects, especially at higher doses or with prolonged use. Common side effects include:

Drowsiness Dizziness Weakness Fatigue Confusion Depression Less common but more serious side effects can include:

Respiratory depression (especially when combined with other CNS depressants) Hypotension Paradoxical reactions (e.g., increased anxiety, agitation, aggression) Dependence and Withdrawal

Chronic use of Lorazepam can lead to physical dependence and tolerance, where higher doses are required to achieve the same therapeutic effect. Abrupt discontinuation after prolonged use can result in withdrawal symptoms such as:

Anxiety Insomnia Irritability Tremors Seizures (in severe cases) Therefore, it is crucial to taper the dose gradually under medical supervision to minimize withdrawal risks.

Interactions

Lorazepam can interact with various medications and substances, leading to enhanced or diminished effects. Notable interactions include:

CNS Depressants: Combining Lorazepam with other CNS depressants (e.g., alcohol, opioids, antihistamines) can potentiate sedative effects and increase the risk of respiratory depression. Antidepressants: Some antidepressants can increase Lorazepam levels by inhibiting its metabolism. Antacids: Some antacids can delay the absorption of Lorazepam, reducing its effectiveness. Special Populations

[Pregnancy and Breastfeeding]

Lorazepam is classified as Category D in pregnancy, indicating potential risks to the fetus. It can cause congenital malformations and withdrawal symptoms in newborns if used during pregnancy. It is also excreted in breast milk, so its use is generally not recommended during breastfeeding. Elderly Patients

Elderly patients are more susceptible to the sedative effects of Lorazepam, increasing the risk of falls and fractures. Lower doses and careful monitoring are recommended. Patients with Liver or Kidney Impairment

Reduced doses are necessary in patients with hepatic or renal impairment due to altered drug metabolism and excretion. Overdose

Lorazepam overdose can result in severe CNS depression, leading to symptoms such as:Italic text

Confusion Drowsiness Hypotonia (reduced muscle tone) Respiratory depression Coma [cases of overdose, supportive measures are critical. Flumazenil, a benzodiazepine receptor antagonist, can be used as an antidote but should be administered with caution due to the risk of precipitating seizures.]

Clinical Case Studies

Case Study 1: Anxiety Management

A 45-year-old woman with generalized anxiety disorder presented with excessive worry, restlessness, and insomnia. She was prescribed Lorazepam 1 mg twice daily. After one week, her anxiety symptoms significantly improved, and she reported better sleep quality. The dosage was tapered off after three months to prevent dependence, with the patient continuing non-pharmacological therapies. Case Study 2: Status Epilepticus

A 28-year-old man with a history of epilepsy was brought to the emergency department in status epilepticus. He received an intravenous injection of 4 mg Lorazepam, which successfully terminated the seizure activity within minutes. He was then stabilized and transitioned to maintenance antiepileptic therapy. Case Study 3: Alcohol Withdrawal

A 55-year-old man with chronic alcoholism presented with tremors, agitation, and a history of withdrawal seizures. He was administered Lorazepam 2 mg orally every 6 hours for the first 24 hours, which effectively controlled his withdrawal symptoms without any adverse effects. The dosage was gradually tapered over the next week. Current Research and Future Directions

Ongoing research aims to optimize the use of Lorazepam and other benzodiazepines, focusing on reducing the risk of dependence and withdrawal. Investigations into alternative delivery methods, such as transdermal patches and novel formulations, seek to enhance patient compliance and minimize side effects. Additionally, exploring the role of Lorazepam in treating other neurological and psychiatric conditions remains an active area of study.

Conclusion

Lorazepam is a versatile and effective medication widely used in the treatment of anxiety, insomnia, seizures, and other conditions requiring sedation. While its benefits are well-documented, it is essential to use Lorazepam 2mg responsibly to avoid dependence and manage side effects. Ongoing research and clinical experience continue to refine its use, ensuring that patients receive the maximum therapeutic benefit with minimal risks.